Status:
COMPLETED
Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS)
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Université Polytechnique de Bobo-Dioulasso
Conditions:
Malnutrition
Eligibility:
All Genders
9-9 years
Phase:
NA
Brief Summary
To assess zinc-related biochemical and functional responses among young Burkinabe children with a presumed high risk of zinc deficiency who receive micronutrient products containing different amounts ...
Detailed Description
Young healthy children will be identified by periodic consensus in the study area. 3200 infants meeting a set of eligibility criteria will be randomly assigned to receive lipid-based nutrient suppleme...
Eligibility Criteria
Inclusion
- 0 to 9.9 mo of age
Exclusion
- severe anemia
- severely malnourished
- presence of bipedal oedema
- severe illness
- congenital abnormalities
- chronic medical condition
- known HIV infection of mother or infant
- history of peanut allergy
- history of anaphylaxis or serious allergic reaction to any substance
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
3220 Patients enrolled
Trial Details
Trial ID
NCT00944281
Start Date
May 1 2010
End Date
December 1 2014
Last Update
July 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Recherche en Sciences de la Sante
Bobo-Dioulasso, Burkina Faso